Insider Transactions in Q4 2023 at Ardelyx, Inc. (ARDX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
225,000
-55.22%
|
$1,350,000
$6.36 P/Share
|
|
Dec 26
2023
|
Justin A Renz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+15.55%
|
$0
$0.99 P/Share
|
|
Dec 18
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.76%
|
$34,050
$6.07 P/Share
|
|
Dec 14
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
7,000
-2.13%
|
$35,000
$5.55 P/Share
|
|
Dec 11
2023
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
50,000
-15.35%
|
$250,000
$5.08 P/Share
|
|
Dec 08
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
20,000
-5.73%
|
$100,000
$5.27 P/Share
|
|
Dec 05
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,272
-2.86%
|
$51,360
$5.0 P/Share
|
|
Nov 30
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.83%
|
$12,000
$4.5 P/Share
|
|
Nov 20
2023
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
11,368
-1.29%
|
$45,472
$4.36 P/Share
|
|
Nov 20
2023
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,873
-0.86%
|
$11,492
$4.36 P/Share
|
|
Nov 20
2023
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,714
-1.34%
|
$18,856
$4.36 P/Share
|
|
Nov 20
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
932
-0.82%
|
$3,728
$4.36 P/Share
|
|
Nov 20
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,835
-0.78%
|
$11,340
$4.36 P/Share
|
|
Nov 20
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,581
-0.96%
|
$10,324
$4.36 P/Share
|
|
Nov 20
2023
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
2,835
-1.08%
|
$11,340
$4.36 P/Share
|
|
Nov 20
2023
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
1,044
-0.88%
|
$4,176
$4.36 P/Share
|
|
Nov 20
2023
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
2,384
-0.73%
|
$9,536
$4.36 P/Share
|
|
Nov 15
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.57%
|
$100,000
$4.0 P/Share
|
|
Oct 10
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,644
-0.45%
|
$6,576
$4.0 P/Share
|